iosr-JPBS   Volume-17 ~ Issue-1 ~ Jan. - Feb. 2022

[1]. Triawanti, Molecular Adipocyte: Konsep Dasar Fisiologi dan Patologi. Airlangga University Press. Surabaya. 2017.
[2]. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6-10. doi:10.1016/j.metabol.2018.09.00
[3]. Blüher M. Metabolically Healthy Obesity. Endocr Rev. 2020;41(3):bnaa004. doi:10.1210/endrev/bnaa004
[4]. Srivastava G, Apovian CM. Current pharmacotherapy for obesity. Nat Rev Endocrinol. 2018;14(1):12-24. doi:10.1038/nrendo.2017.122
[5]. Gitawati R, Widowati L, Suharyanti F. Penggunaan Jamu pada Pasien Hiperlipidemia Berdasarkan Data Rekam Medik, di Beberapa Fasilitas Pelayanan Kesehatan di Indonesia. Jurnal Kefarmasian Indonesia Vol. 5 no. 1, 2015, pp. 41-48.

[1]. Pleasen C V, Kodal A M, Anhoj J. Experiences with global trigger tool reviews in five Danish hospitals: An implementation study. BMJ Open[INTERNET]. 2012;2:e001324. Doi:10.1136/bmjopen-2012-001324.
[2]. Howard I, Pillay B et al. Application of the emergency medical services trigger tool to measure adverse events in prehospital emergency care: a time series analysis. BMC Emergency Medicine [INTERNET] (2018) 18:47,1-10. https://doi.org/10.1186/s12873-018-0195-04
[3]. Rutberg H , Risberg M B et al. Characterisations of adverse events detected in a university hospital: A 4-year study using the Global Trigger Tool method . BMJ open [INTERNET] 2014; 4:e004879. Doi:10.1136/bmjopen-2014-004879
[4]. Brenner S, Detz A et al. Signal and noise: Applying a laboratory trigger tool to identify adverse drug events among primary care patients. BMJ Journals [INTERNET]. 2012; 21:670e675. doi:10.1136/bmjqs-2011-000643.

[1]. Soeka, Y. S., Suharna, N. & Triana, E. Characterization of Cellulase Enzyme Produced by Two Selected Strains of Streptomyces Macrosporeus Isolated from Soil in Indonesia. Makara J. Sci. 23, (2019).
[2]. Widia, I. & Wathoni, N. Review Artikel Selulosa Mikrokristal: Isolasi, Karakterisasi Dan Aplikasi Dalam Bidang Farmasetik. J.Farmaka 15, 127–143 (2014).
[3]. Aris, M., Sukenda, Harris, E. & Sukadi, M. F. Identifikasi molekular bakteri patogen dan desain primer PCR. Budid. Perair. 1, 43–50 (2013).
[4]. Fialová, E., Zdeňková, K., Jablonská, E., Demnerová, K. & Ovesná, J. Digital polymerase chain reaction: Principle and applications. Chem. List. 113, 545–552 (2019).
[5]. Fatmawati, F. Xylanase and Cellulase ' s Screening From Bacillus cereus. 7, 40–43 (2021).

[1]. Stübinger J, Schneider L. Epidemiology of Coronavirus COVID-19: Forecasting the Future Incidence in Different Countries. Healthcare 2020; 8(2):99.
[2]. Ranney ML, Griffeth V, Jha AK. Critical supply shortages – the need for ventilators and personal protective equipment during the COVID-19 pandemic. N Engl J Med 2020; 382: e4.
[3]. The world Health Organization (WHO). WHO Coronavirus (COVID-19) report. Available from : https://covid19.who.int/ (Accessed 18 September 2020).
[4]. Organisation Mondiale de la santé. Nouveau coronavirus (2019-nCov).Genève : OMS ; 2020. Consulté le 29/09/2020 et accessible sur : https://covid19.who.in.
[5]. Organisation Mondiale de la Santé.COVID-19 in the WHO African Region https://who.maps.arcgis.com/apps/opsdashboard/index.html#/0c9b3a8b68d0437a8cf28581e9c063a9. Consulté le 29/09/2020.
[6]. DRC Ministry of Health. COVID-19 epidemiological status in Democratic Republic of Congo. Consulté le 17 Septembre 2020 à 23H04', et accessible sur : https://www.stopcoronavirusrdc.info/.

[1]. Abdalhamid, B., Elhadi, N., Alabdulqader, N., Alsamman, K. and Aljindan, R. (2016). Rates of gastrointestinal tract colonization of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa in hospitals in Saudi Arabia. New microbes and new infections, 10, pp.77-83.
[2]. Ahmad, S., Alotaibi, M.A. and Alamri, M.S. (2020). Antibiotic Sensitivity Pattern of Clinical Isolates of Pseudomonas aeruginosa at a Tertiary Care Hospital in Saudi Arabia. Dhaka University Journal of Pharmaceutical Sciences, 19(1), pp.77-82.
[3]. Al-Agamy, M.H., Jeannot, K., El-Mahdy, T.S., Shibl, A.M., Kattan, W., Plésiat, P. and Courvalin, P. (2017). First detection of GES-5 carbapenemase-producing Acinetobacter baumannii isolate. Microbial Drug Resistance, 23(5), pp.556-562.
[4]. Al-Gethamy, M.M., Faidah, H.S., Adetunji, H.A., Haseeb, A., Ashgar, S.S., Mohanned, T.K., Mohammed, A.H., Khurram, M. and Hassali, M.A. (2017). Risk factors associated with multi-drug-resistant Acinetobacter baumannii nosocomial infections at a tertiary care hospital in Makkah, Saudi Arabia-a matched case–control study. Journal of International Medical Research, 45(3), pp.1181-1189.
[5]. Ali, A. (2018). Antimicrobial Resistance Pattern of Uropathogens Isolated from Rafha Central Hospital, Rafha, Kingdom of Saudi Arabia. Journal of Pure and applied Microbiology, 12(2), pp.577-586.

[1]. OMS (2000), Médicaments Essentiels : le Point, Le Point No 28 & 29, 2000.
[2]. CARLET J., RAMBAUD C., PULCINI C. Alliance contre les bactéries multirésistantes : sauvons les antibiotiques ! Alliance against MDRO: Safeguarding antibiotics. Annales Francaises d'Anesthésie et de Réanimation 31(2012) 704-708.
[3]. CAVALLO J-D., R. FABRE R., JEHL F., RAPP C., GARRAB E. Bêtalactamines. EMC-Maladies Infectieuses 1 (2004) 129-202.
[4]. ANSM. Caractérisation des antibiotiques considérés comme « critiques», Diffusé en Novembre 2013- www.ansm.sante.fr
[5]. OMS. Niveaux élevés de résistance aux antibiotiques dans le monde, GLASS : Communiqué de presse du 29 janvier 2018, BANGKOK. www.who.int

[1]. Aisha, S. B., Kutama, A. S., Kabir, S and Paul, A. T. (2016). Phytochemical Screening and Antifungal Activity Of Moringaoleiferaon Some Selected Fungi in Dutse, Jigawa State, Global Advanced Research Journal of Agricultural Science, 5(6):243-248.
[2]. Akpan, M. M., Odeomena, C. S., Nwachukwu, C. N and Danladi, B (2012). Antimicrobial assessment of ethanolic extract of Costusafer leaves, Asian Journal of Plant Science and Research, 2(3); 335-341
[3]. Anaga A. O., Njoku C. J., Ekejiuba, E. S., Esiaka, M. N and Asuzu, I. U (2004). Investigation of the methanolic leaf extract of Costusafer Ker for pharmacological activities invitro and in vivo, Phytomedicine, 11(9): 242-248.
[4]. Anyasor, G. N., Ogunwenmo, K. O., Oyelana, O. A and Akpofunure, B. E (2010). Phytochemical constituents and antioxidant activities of aqueous and methanol stem extracts of Costusafer Ker Gawl. (Costaceae). African Journal of Biotechnology, 9 (31):4880-4884:
[5]. Edeoga, H. O and Okoli, B. E (2000). Chromosome numbers of Costuslucanusianus(Costaceae) in Nigeria, Folia Geobotanica, 35: 315-318

[1]. Matsumoto, T., Szasz, T., Tostes, R.C. & Webb, R.C. 2012, "Impaired beta-adrenoceptor-induced relaxation in small mesenteric arteries from DOCA-salt hypertensive rats is due to reduced KCa channel activity", Pharmacological Research : The Official Journal of the Italian Pharmacological Society, Vol. 65, no. 5, pp. 537-545.
[2]. Abdelkrim, M.A., Leonetti, D., Montaudon, E., Chatagnon, G., Gogny, M., Desfontis, J.C., et al. 2014, "Antibodies against the second extracellular loop of beta(1)-adrenergic receptors induce endothelial dysfunction in conductance and resistance arteries of the wistar rat", International Immunopharmacology, Vol. 19, no. 2, pp. 308-316.
[3]. Patel, P.A. & Hernandez, A.F. 2013, "Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy", European Journal of Heart Failure, Vol. 15, no. 7, pp. 724-729.
[4]. Lands, A.M., Arnold, A., McAuliff, J.P., Luduena, F.P. & Brown, T.G.,Jr 1967, "Differentiation of receptor systems activated by sympathomimetic amines", Nature,Vol. 214, no. 5088, pp. 597-598.
[5]. Nakane, T., Tsujimoto, G., Hashimoto, K. & Chiba, S. 1988, "Beta adrenoceptors in the canine large coronary arteries: Beta-1 adrenoceptors predominate in vasodilation", The Journal of Pharmacology and Experimental Therapeutics, Vol. 245, no. 3, pp. 936-943.

[1] PERKENI, Guidelines for the Management and Prevention of Type 2 Diabetes Mellitus in Indonesia, " Endocrinol Society, Indonesia,pp. 2019; 1-117
[2] BG. Wells, JT Dipiro. TL Schwinghammer, and c, V. Dipiro, Pharmacotherapy Handbook. 2015
[3] American Diabetes Association, "Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2020," Diabetes Care, vol. 43, no. January, pp. S14–S31, 2020, doi: 10.2337/dc20-S002.
[4] Ministry of Health of the Republic of Indonesia, "Stay Productive, Prevent and Overcome Diabetes Mellitus," Data center and information from the Indonesian Ministry of Health. 2020
[5] IDF,2013, IDF Diabetes Atlas Sixth Edition,International Diabetes Federation.